Attached files

file filename
EX-10.1 - PATENT PURCHASE AGREEMENT BETWEEN SPHERIX INCORPORATED AND ROCKSTAR CONSORTIUM US LP (REDACTED) - AIkido Pharma Inc.ex10-1.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K/A
(Amendment No. 1)
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): August 19, 2013
 
SPHERIX INCORPORATED
(Exact Name of Registrant as Specified in Charter)
 
Delaware
 
0-5576
 
52-0849320
(State or other jurisdiction
of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)
 
7927 Jones Branch Drive, Suite 3125
Tysons Corner, VA
     
22102
(Address of principal executive offices)
     
(Zip Code)
 
Registrant’s telephone number, including area code: (703) 992-9260
 
 
(Former name or former address, if changed since last report)
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 
 
Explanatory Note:

This amendment on Form 8-K/A (the “Amendment”) amends the Current Report of Spherix Incorporated (the “Company”) on Form 8-K, as initially filed with the Securities and Exchange Commission (the “Commission”) on August 21, 2013 (the “Original Report”), solely to replace the redacted agreement presented as Exhibit 10.1 to the Original Report with a revised redacted agreement in order to comply with the Staff’s comments relating to the Company’s Application for Confidential Treatment for the above referenced redacted agreement.

Exhibit 10.1 is amended and restated in its entirety.  Except for Exhibit 10.1, no other changes have been made to Original Report. This Amendment speaks as of the original filing date of the Original Report, does not reflect events that may have occurred subsequent to the original filing date and does not modify or update in any way disclosures made in the Original Report.

 
 

 
 
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
 
(d)  Exhibits
 
    The exhibit listed in the following Exhibit Index is furnished as part of this amended Current Report on Form 8-K/A.

Exhibit No.
 
Description
10.1
 
Patent Purchase Agreement between Spherix Incorporated and Rockstar Consortium US LP (redacted)* 
 
*Confidential treatment has been requested for this exhibit and confidential portions have been filed with the Securities and Exchange Commission.

 
 

 
 
SIGNATURES
 
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
Date:  September 27, 2013
 
 
SPHERIX INCORPORATED
   
By:  
 /s/ Anthony Hayes
 
Name: Anthony Hayes
 
Title: Chief Executive Officer